Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIA
3951
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $153K | ﹤0.01% |
25,422
-218,333
| -90% | -$1.22M |
|
3952
Eagle Materials
EXP
$6.57B
| $152K | ﹤0.01% |
2,194
+71
| +3% | +$4.13K |
|
3953
CALL
Lincoln National
LNC
$8.51B
| $152K | ﹤0.01% |
3,900
-11,700
| -75% | -$457K |
|
3954
PUT
Steel Dynamics
STLD
$37.8B
| $152K | ﹤0.01% |
6,900
-6,900
| -50% | -$130K |
|
3955
PUT
Ubiquiti
UI
$34.7B
| $152K | ﹤0.01% |
4,600
-20,700
| -82% | -$642K |
|
|
PTLA
3956
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $152K | ﹤0.01% |
7,579
+1,661
| +28% | +$52.7K |
|
|
TRR
3957
DELISTED
Trc Companies
TRR
| $152K | ﹤0.01% |
21,700
-16,000
| -42% | -$120K |
|
3958
PUT
AeroVironment
AVAV
$9.92B
| $151K | ﹤0.01% |
+5,400
| New | +$141K |
|
3959
PUT
Brookfield Infrastructure Partners
BIP
$18.1B
| $151K | ﹤0.01% |
9,072
+1,260
| +16% | +$18.3K |
|
3960
CALL
Cintas
CTAS
$82.1B
| $151K | ﹤0.01% |
6,800
+5,200
| +325% | +$112K |
|
3961
CALL
Louisiana-Pacific
LPX
$5.28B
| $151K | ﹤0.01% |
8,900
| – | – |
|
3962
PUT
Avnet
AVT
$7.87B
| $150K | ﹤0.01% |
3,400
-600
| -15% | -$24.6K |
|
|
EDN
3963
Edenor
EDN
$1.01B
| $150K | ﹤0.01% |
9,400
-2,600
| -22% | -$42.7K |
|
|
OSMS
3964
DELISTED
BARCLAYS BK PLC BARCLAYS OFI STEELPATH MLP ETN (GBR)
OSMS
| $150K | ﹤0.01% |
10,000
-978,000
| -99% | -$14.2M |
|
3965
CALL
America Movil
AMX
$70.3B
| $149K | ﹤0.01% |
9,900
-1,100
| -10% | -$15.2K |
|
3966
PUT
ING
ING
$101B
| $149K | ﹤0.01% |
13,500
+9,200
| +214% | +$110K |
|
3967
CALL
iShares Russell 1000 Growth ETF
IWF
$127B
| $149K | ﹤0.01% |
6,000
+4,000
| +200% | +$94.5K |
|
3968
PUT
iShares Russell 2000 Value ETF
IWN
$14.6B
| $149K | ﹤0.01% |
+1,600
| New | +$139K |
|
3969
PUT
Omnicom Group
OMC
$23.6B
| $149K | ﹤0.01% |
1,800
+1,000
| +125% | +$75.3K |
|
|
NATI
3970
DELISTED
National Instruments Corp
NATI
| $149K | ﹤0.01% |
4,967
-6,014
| -55% | -$173K |
|
3971
CALL
Euronet Worldwide
EEFT
$2.64B
| $148K | ﹤0.01% |
2,000
-1,800
| -47% | -$127K |
|
3972
MillerKnoll
MLKN
$1.62B
| $148K | ﹤0.01% |
4,954
+1,386
| +39% | +$36.8K |
|
3973
Boston Beer
SAM
$1.85B
| $148K | ﹤0.01% |
795
-4,882
| -86% | -$890K |
|
3974
Williams-Sonoma
WSM
$29.5B
| $148K | ﹤0.01% |
5,476
-6,226
| -53% | -$169K |
|
3975
CALL
Xylem
XYL
$28.8B
| $148K | ﹤0.01% |
3,700
+2,200
| +147% | +$81K |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.